Questions to Ask Your Pulmonologist Before Starting Long-Term Pulmonary Disease Treatment

The appointment is at 2:40. By 2:15 the piece of paper has been folded and unfolded so many times the crease is going soft. On it, in pencil, are seven questions that seemed urgent at the kitchen table and now look either too obvious or too big to say out loud in a fifteen-minute slot.

Most people walk into a lung clinic with some version of that paper, and most walk out having asked two of the seven. The gap is not shyness. Long-term pulmonary disease treatment arrives with its own vocabulary, and it is hard to interrogate something you cannot yet name. Knowing the right questions to ask a pulmonologist, and knowing why each one matters, closes that gap faster than any leaflet.

This explainer is built around the conversation itself: what the first visit involves, how the common treatments actually work, who is usually offered them, and which answers are worth pressing for before you say yes.

What does a pulmonologist treat, and why were you referred?

A pulmonologist is a physician who has trained in internal medicine and then specialized in the lungs and breathing. Primary care clinicians manage a great deal of lung disease themselves; a referral usually means something needs a closer look, a second set of tests, or a treatment plan that will run for years rather than weeks.

People often ask which three conditions a pulmonologist treats. There is no official trio, but three account for a large share of clinic time. Chronic obstructive pulmonary disease, or COPD, is a long-term narrowing and damage of the airways and air sacs, most often linked to smoking. The Centers for Disease Control and Prevention notes that nearly 16 million adults in the United States have been diagnosed with it, with millions more thought to be undiagnosed. Asthma is the second: airway inflammation that flares and settles. Interstitial lung disease, the third, is a family of conditions in which the lung tissue itself becomes scarred or inflamed; idiopathic pulmonary fibrosis, where the cause is unknown, is the most discussed member.

Beyond those three, the same clinic sees sleep-related breathing disorders, persistent cough, lung infections that will not clear, nodules found by chance on a scan, and breathlessness nobody has explained. The referral letter should say which of these concerns triggered your visit. If you have not seen it, ask for the reason in one sentence. That single sentence shapes everything that follows, from the tests ordered to the treatments proposed, and it is the first thing worth understanding before you talk about starting anything long term.

What to expect at a pulmonologist appointment on the first visit

The first visit is mostly listening, then measuring. Expect a detailed history: when the breathlessness started, what brings it on, how many stairs you can climb now compared with two years ago, whether you wake at night coughing, what you have inhaled at work or at home, and every cigarette, vape or wood stove in your past. Bring a list of your medicines, including inhalers you no longer use and anything bought over the counter.

The examination itself is brief. A stethoscope on the chest, a look at your fingertips and lips, a small clip on your finger called a pulse oximeter, which estimates how much oxygen your blood is carrying. Then come the tests that turn a story into numbers.

Spirometry is the anchor. It is a breathing test in which you blow as hard and as long as you can into a mouthpiece connected to a machine. The NHS describes a spirometry appointment as usually taking 30 to 90 minutes, partly because the maneuver is repeated and partly because you may be asked to inhale a bronchodilator, a medicine that relaxes airway muscle, and blow again to see whether the numbers change. That second run is called reversibility testing and helps distinguish asthma from COPD.

Depending on the question, the pulmonologist may also order a chest X-ray or a CT scan, a more detailed cross-sectional image, a walk test that tracks oxygen levels while you move, or blood tests. Some of these happen the same day; others are scheduled. Ask before you leave which results will arrive first and whether the treatment discussion will wait until all of them are in. Very often it should.

How to read your pulmonary function test results before agreeing to treatment

Ask for a printed copy of your spirometry. Then ask for a three-minute walk through it. The numbers are less intimidating than they look, and understanding them is the difference between accepting a diagnosis and owning it.

FEV1 stands for forced expiratory volume in one second: the amount of air you can push out in the first second of a hard exhale. FVC, forced vital capacity, is the total amount you can blow out. The ratio of the two tells the clinician whether your airways are obstructed, meaning air leaves more slowly than it should. Each value is also expressed as a percentage of what would be predicted for someone of your age, sex, height and ancestry, so a low FEV1 percent predicted means you are moving less air than expected, not simply less than a young athlete.

If the bronchodilator made a clear difference, that points toward a reversible component, which is typical of asthma. If it made little difference, the picture fits COPD or another fixed narrowing. Neither result is a verdict on its own; the pulmonologist reads it against your history and imaging.

Two further tests may appear on the sheet. Lung volumes measure how much air your lungs hold in total. DLCO, the diffusing capacity, estimates how well gas passes from the air sacs into the blood; it tends to fall in scarring conditions and in emphysema, the type of COPD where air sacs are destroyed.

Useful questions here: which number concerns you most, how far is it from normal, and what result would you want to see at my next test? A pulmonologist who can answer the third question has already told you how success will be measured.

Questions to ask a pulmonologist about the diagnosis itself

Treatment conversations go badly when the diagnosis underneath them is softer than it sounds. So before anyone reaches for a prescription pad, spend your first questions on the label.

Start with confidence. Ask how certain the diagnosis is, on a scale the clinician is comfortable using, and what else was considered. Breathlessness has many authors: heart failure, anemia, deconditioning, anxiety and lung disease can all produce it, and two can coexist. Asthma and COPD overlap in some people, which changes what is prescribed. Interstitial lung disease can take more than one scan and a multidisciplinary discussion to pin down, and the NHS notes that idiopathic pulmonary fibrosis is diagnosed partly by ruling other causes out.

Then ask about mechanism in plain words. Is my problem mainly narrowed airways, damaged air sacs, scarred tissue, or a mix? The answer predicts which treatments are even relevant; a bronchodilator can open a tight airway but cannot soften scar.

Ask what stage or severity you are at and what that grading is based on. Ask what is likely to make it worse, and be specific: smoke, dust, infections, weight, altitude, particular jobs. Ask whether any part of it is reversible, and which parts are not, because hoping for the wrong kind of improvement is a quiet source of disappointment months later.

Finally, ask what would change the diagnosis. If a scan in a year looks different, or the spirometry shifts, does the label move? Long-term treatment should rest on a diagnosis that has been stress-tested, and asking these questions is how you watch that happen.

Who is usually offered long-term treatment, and who is asked to wait

Not everyone who leaves a lung clinic leaves with a new treatment, and being asked to wait is not the same as being dismissed.

Long-term therapy is generally proposed when three things line up: symptoms that persist or interfere with daily life, objective evidence on tests or imaging, and a reasonable expectation that the treatment will change the course or the experience of the disease. In COPD, that usually means confirmed airflow obstruction plus breathlessness or repeated flare-ups, called exacerbations, in which symptoms worsen sharply for days. In asthma, it means symptoms or attacks frequent enough that a preventer approach makes sense. In fibrosis, it means a confirmed pattern of scarring that specialists consider likely to progress.

Watchful waiting is common in several situations. A small lung nodule found by chance is often followed with repeat scans rather than treated. Mild spirometry changes in someone with few symptoms may be rechecked before any inhaler is started. An unclear interstitial pattern may go to a specialist team meeting first. Someone who still smokes will usually be told, with reason, that stopping is the single most effective step; the NHS states plainly that quitting smoking is the most important thing a person with COPD can do, and no inhaler substitutes for it.

Waiting should come with a plan. Ask what is being watched, what result would trigger treatment, when the next test is due, and what you should do if symptoms change before then. Ask, too, whether there is anything to start now that is not a medicine: pulmonary rehabilitation, vaccination, breathing techniques, activity. Being asked to wait for a prescription rarely means being asked to do nothing.

How long-term lung treatments actually work

The treatments you may be offered fall into a few mechanical families, and knowing the family tells you what each can and cannot do.

Bronchodilators relax the muscle wrapped around the airways so the tube widens and air moves more easily. Short-acting versions work within minutes and wear off within hours; long-acting versions are designed for daily use to keep airways open. In COPD they are the backbone of long-term care, as the NHS and Mayo Clinic both describe. They ease the sensation of breathlessness and can reduce flare-ups, but they do not repair damaged tissue.

Inhaled corticosteroids dampen inflammation inside the airway lining. In asthma they are central, because inflammation drives the disease. In COPD they are added for particular groups, often those with frequent exacerbations, rather than for everyone. Combination inhalers put two or three of these mechanisms in one device.

Antifibrotic medicines, used in idiopathic pulmonary fibrosis, work differently again. They aim to slow the laying-down of scar tissue. The NHS describes them as treatments that can slow progression rather than reverse existing damage, which means you may not feel better day to day even when they are doing their job.

Oxygen therapy is not a medicine for breathlessness in the usual sense; it is prescribed when tests show blood oxygen is persistently low, to protect the heart and other organs. Pulmonary rehabilitation is a structured program of supervised exercise, education and breathing training that improves stamina and confidence. Vaccination against influenza and pneumococcal infection reduces the risk of the chest infections that trigger flares.

Which of these fits you, and in what sequence, is the prescribing clinician’s call. Understanding the mechanism is what lets you ask why.

Long-term pulmonary treatment options at a glance

Seeing the main approaches side by side makes it easier to spot which questions belong to which treatment. The table is a map for the conversation, not a menu; your pulmonologist decides what is appropriate, and some rows will not apply to your condition at all.

Approach	What it does	Typically considered for	Worth asking
Long-acting bronchodilator inhalers	Relax airway muscle to keep airways open through the day	COPD with persistent symptoms; some asthma alongside a preventer	How will my technique be checked, and how often?
Inhaled corticosteroids	Reduce airway inflammation	Most persistent asthma; selected COPD with frequent flares	Why do I need this component, and what would prompt stopping it?
Antifibrotic medicines	Slow formation of scar tissue	Confirmed idiopathic pulmonary fibrosis	How will you tell it is working if I do not feel different?
Long-term oxygen	Raises blood oxygen when tests show it is persistently low	Chronic low oxygen confirmed on blood or oximetry testing	How many hours a day, and when will the need be reassessed?
Pulmonary rehabilitation	Supervised exercise, education and breathing training	Most people with COPD and many with fibrosis or other chronic lung disease	Am I eligible now, and how do I enroll?
Vaccination and smoking cessation support	Prevent infections and remove the main driver of progression	Nearly everyone with chronic lung disease	Which vaccines, and what support is available to quit?

Two rows deserve emphasis. Pulmonary rehabilitation is offered far less often than guidelines suggest it should be, and people rarely ask for it because it does not sound like treatment. The NHS describes a typical program as two or more group sessions a week for at least six weeks. The vaccination row is equally undersold: the infections it prevents are among the commonest reasons lung disease suddenly worsens.

Questions to ask about COPD, asthma and pulmonary fibrosis treatment goals

The most useful question in the room is also the least asked: what is this treatment for? Not in general, but for you, this year.

Goals differ by condition and by person. In COPD, treatment usually aims to ease breathlessness, reduce the number and severity of exacerbations, and keep you active; Mayo Clinic frames it as controlling symptoms and slowing progression rather than restoring lost lung function. In asthma, the goal is often stated more ambitiously: few or no symptoms, no night waking, no attacks, and rare use of a reliever inhaler. In idiopathic pulmonary fibrosis, the honest goal of antifibrotic therapy is to slow the rate at which lung function declines, and the NHS is explicit that existing scarring does not reverse.

Those differences matter because they change what counts as success. If your COPD treatment is meant to reduce flares, then a year with one exacerbation instead of three is a good year, even if your spirometry number barely moved. If your fibrosis treatment is meant to slow decline, a stable FVC at your next test is the win, not a feeling of lighter breathing.

So ask: which of my symptoms should improve, and by roughly when? Which will not change? What measurement will we look at to decide whether to continue? What would make you say this is not working? And what matters most to me, whether that is walking to the grocery store, sleeping through the night, or keeping a job, and does this plan address it?

Write the answers next to the treatment name. Six months later, that note is how you and your pulmonologist judge the plan fairly, instead of by how you happen to feel on the day of the follow-up.

What the first weeks of long-term treatment usually look like

Starting long-term therapy is less an event than a run-in period, and knowing its shape prevents the two commonest early mistakes: abandoning a treatment before it has had a chance, and tolerating a problem that should have prompted a call.

If an inhaler is prescribed, the first task is technique. Studies cited by the NHS and Mayo Clinic repeatedly find that a large share of people use inhalers incorrectly, and a medicine that lands on the back of the throat instead of in the airways cannot work. Ask to demonstrate your technique before you leave, and again at the first follow-up. Spacers, holding-chamber devices that slow the spray so more reaches the lungs, are often suggested for certain inhaler types.

Expect the effects of different treatments to arrive on different clocks. A bronchodilator changes airflow quickly; an anti-inflammatory approach builds more gradually; an antifibrotic may produce no felt change at all, with benefit visible only on repeat testing. Your pulmonologist can tell you which clock you are on. Ask.

A symptom record helps. A few lines a day on breathlessness, cough, sleep and reliever use gives the follow-up appointment something firmer than memory. Pulse oximeter readings can be added if your team wants them, along with the personal range they consider acceptable for you.

If pulmonary rehabilitation has been recommended, the referral often takes weeks to convert into a start date, so ask who is chasing it. Vaccinations may be scheduled in this window too. And confirm, before you leave, when the first review is and what will happen at it: repeat spirometry, a walk test, blood tests if the medicine requires monitoring, or simply a conversation about how the plan feels in real life.

Questions to ask a pulmonologist about side effects, monitoring and follow-up

Every effective treatment has a shadow, and the fair way to weigh one is to ask about the shadow in advance rather than discover it at the pharmacy counter.

Ask which side effects are common and mild, which are uncommon but serious, and which need a same-day call. Inhaled corticosteroids, for example, can cause hoarseness or oral thrush, a yeast infection of the mouth; the NHS notes that rinsing after use reduces the risk. Some bronchodilators cause tremor, palpitations or a dry mouth. Antifibrotic medicines are associated with digestive upset, appetite change and sun sensitivity, and require periodic blood tests. Oxygen carries fire-safety obligations at home. Your pulmonologist will know the specific profile of whatever is proposed; your job is to ask for it in plain language and to say which risks you would find hardest to live with.

Then ask about monitoring. What will be measured, how often, and what result would change the plan? How long will we try this before deciding it is not the right fit? Is there anything I should stop, or avoid combining, while I take it? Are there interactions with my other medicines, including supplements?

Ask about the practical layer too. Who do I contact between appointments, and how quickly can I expect a reply? What is the plan if I have a flare at the weekend? Will I be given a written action plan that spells out what to do at each stage of worsening? Guidelines for both asthma and COPD favor exactly this kind of document.

None of these questions signals distrust. They signal that you intend to be a reliable partner in a plan that will run for years, and most clinicians welcome that.

What people often get wrong about long-term lung treatment

Lung disease attracts a particular set of half-truths, and several of them quietly sabotage treatment before it starts.

The first is that inhalers are addictive or that the body gets used to them. Bronchodilators and inhaled steroids do not cause dependence. Needing them daily reflects a chronic condition, not a habit; the disease is the reason, not the device. A related error is stopping a preventer inhaler because you feel well, which in asthma is often precisely when it is working.

The second is that oxygen is a last resort, reserved for the final stretch of illness. In practice it is prescribed on the basis of measured blood oxygen, sometimes years before any end-of-life discussion, to protect the heart and brain. Declining it out of dread can cause harm the treatment was meant to prevent.

The third is that a normal chest X-ray means the lungs are fine. X-rays are poor at showing early COPD and can miss interstitial changes that a CT scan and spirometry reveal. Normal imaging with abnormal breathing tests is common.

The fourth is that pulmonary rehabilitation is just a gym class for people who are already fit. It is designed for people who become breathless walking to the mailbox, and MedlinePlus describes it as a program that helps people with chronic lung disease breathe better and function more easily in daily life.

The fifth is that if treatment does not help, the patient did something wrong. Lung disease varies, medicines suit some people and not others, and a plan that needs revising is a normal part of chronic care, not a failure. Asking for the revision is part of the job.

If you only have time for four questions, ask these

Appointments run short. If the paper with seven questions has to shrink to four, these are the four that do the most work, because each one forces a specific answer rather than reassurance.

First: what exactly do my tests show, and how sure are you of the diagnosis? This anchors everything. A pulmonologist who walks you through your FEV1 and your scan has told you what is being treated and how firmly the ground holds.

Second: what is this treatment meant to change for me, and by when will we know? The answer separates treatments that should ease symptoms from those that only slow decline, and it sets the date on which the plan will be judged.

Third: what should make me call you, and how do I reach you? This produces the red-flag list and the phone number, both of which matter more on a bad night than any leaflet.

Fourth: what are my alternatives, including doing nothing for now? Every proposed treatment sits alongside options: a different class, a non-medicine approach, watchful waiting, a referral for rehabilitation, a discussion at a specialist meeting. Hearing them named helps you understand why this one was chosen and makes the eventual yes a real one.

People also ask what they would say if they had a chance to meet a pulmonologist informally rather than as a patient. The honest answer is the same four questions, asked about the disease in general: what does the test tell you, what can treatment change, what should worry me, what else is there. Good questions do not change much between the corridor and the consulting room.

Questions to ask your care team: a checklist to bring

Below is the longer list, grouped so you can pick the rows that fit your situation. Bring it printed, tick what you have covered, and hand the rest to the nurse or pharmacist if the doctor’s time runs out; they answer many of these questions every day.

About the diagnosis:

• What do my spirometry, imaging and other tests show, in plain words?
• How confident are you, and what else was considered?
• Is any of this reversible, and which parts are not?

About the treatment:

• How does this work in my lungs, and what is it meant to change?
• Why this option rather than the alternatives, including waiting?
• How will my inhaler technique be checked?
• What non-medicine steps should start alongside it, such as rehabilitation, vaccination or quitting support?

About safety and monitoring:

• Which side effects are common, which are serious, and which need a same-day call?
• What tests will monitor me, and how often?
• Does this interact with anything else I take?
• How long is a fair trial before we reconsider?

About daily life and flares:

• Can I have a written action plan for worsening symptoms?
• Who do I contact between visits, and how fast will they respond?
• Is it safe for me to exercise, travel or fly, and what precautions apply?
• What should family members know or watch for?

About what comes next:

• When is my next review and what will happen at it?
• What result would make you change or stop this treatment?
• Is a second opinion or a specialist team discussion reasonable in my case?

None of these questions has a single right answer, and the answers will differ between two people with the same diagnosis. That is exactly why they are worth asking of your own team, and worth writing down when you do.

When to call your doctor

Long-term treatment is built for stability, and a written action plan from your team should tell you what to do at each step of worsening. Even so, some signs should never wait for the next scheduled visit.

Call your pulmonologist or primary care team the same day if breathlessness is noticeably worse than your usual over a day or two, if you are coughing up more sputum or it has changed color, if you have a fever alongside chest symptoms, if you are needing your reliever inhaler far more than usual, if new swelling appears in your ankles, or if your home oxygen readings sit below the personal range your team gave you. These are the common early signals of an exacerbation or infection, and early advice often keeps a flare small.

Call emergency services, or have someone take you to an emergency department immediately, if you are struggling to breathe at rest or cannot finish a sentence, if your lips or fingertips look blue or gray, if you have sudden chest pain, if you cough up blood, if you become confused, unusually drowsy or agitated, or if a reliever inhaler is giving no relief. Sudden severe breathlessness with sharp chest pain can also signal a blood clot in the lung or a collapsed lung, both of which need urgent assessment.

A separate category deserves a call rather than silence: side effects that are making you want to stop. Skipping doses quietly, or stopping altogether without telling anyone, leaves your team judging a plan you are no longer following. Say so, and let them adjust it with you. The decision about what to change always rests with the prescribing clinician, but it rests on information only you can supply.

Frequently asked questions

What four questions will you ask a pulmonologist?

The four highest-value questions are: what do my tests show and how certain is the diagnosis; what is this treatment meant to change for me and by when will we know; what symptoms should make me call you and how do I reach you; and what are the alternatives, including waiting. Each forces a specific answer rather than general reassurance, and together they cover diagnosis, goals, safety and choice in a short appointment.

What are the three conditions treated by a pulmonologist?

There is no official list, but three dominate lung clinics: chronic obstructive pulmonary disease, asthma, and interstitial lung disease, which includes pulmonary fibrosis. Pulmonologists also manage sleep-related breathing disorders, persistent cough, lung nodules, chronic infections and unexplained breathlessness. Your referral letter should state which concern prompted your visit, and asking for that reason in one sentence is a sensible way to open the first appointment.

What will a pulmonologist do on a first visit?

A first visit combines a detailed history of your symptoms, exposures and medicines with a brief physical examination and measurement. Most people have spirometry, a breathing test into a mouthpiece, and a pulse oximeter reading of blood oxygen. Depending on the question, a chest X-ray, CT scan, walk test or blood tests may be ordered the same day or scheduled. Treatment decisions are often deferred until those results are complete.

What are the most useful questions to ask about COPD treatment?

Ask what the treatment is meant to change, since COPD care usually aims to ease breathlessness and reduce flare-ups rather than restore lost function. Ask how your inhaler technique will be checked, whether pulmonary rehabilitation is available to you, which vaccines are advised, and what support exists to stop smoking if you still do. Ask for a written action plan describing what to do when symptoms worsen and whom to call.

How do I understand my pulmonary function test results?

Ask for a printed copy and a short walk-through. FEV1 is the air you force out in one second, FVC is the total you can exhale, and their ratio shows whether airflow is obstructed. Each is given as a percentage of the value predicted for your age, sex, height and ancestry. If the numbers improve after a bronchodilator, that suggests a reversible component typical of asthma. Ask which number matters most and what result your pulmonologist hopes to see next time.

Should I bring someone with me to the appointment?

Yes, if you can. A second person hears what you miss, keeps the list of questions on track, and can write down answers while you talk. Long-term treatment discussions involve new vocabulary and several decisions at once, and recall afterward is often incomplete. If nobody can come, ask whether you may record the conversation on your phone, or request a written summary of the plan before you leave.

What does a pulmonologist treat that is not a lung disease?

Several conditions on a pulmonologist’s list sit at the edge of lung disease proper. Sleep-related breathing disorders, in which breathing pauses during sleep, are commonly managed in lung clinics. Breathlessness caused by heart problems, anemia or deconditioning is often investigated there first, because the lungs need to be checked before other causes are pursued. Chronic cough with normal lung tests is another frequent referral that may turn out to have a non-lung origin.

Can I ask for a second opinion before starting long-term treatment?

You can, and asking is a normal part of chronic care rather than an insult. It is especially reasonable when the diagnosis is uncertain, when the treatment proposed is lifelong, or when the condition is uncommon, as with many forms of interstitial lung disease, which are often discussed at multidisciplinary specialist meetings. Say plainly that you would like a second view, and ask your current team how best to arrange it and what records to share.

What if I am not sure I want to start treatment yet?

Say so, and ask what waiting would involve. In some situations, such as mild test changes with few symptoms or a small nodule, watchful waiting with repeat tests is a standard option. In others, delay carries risk, and your pulmonologist should explain what that risk is. Ask what would be monitored, what result would trigger treatment, and what non-medicine steps could start now. The decision remains yours, made with the treating team’s information.

How often will I need to see my pulmonologist once treatment starts?

Frequency depends on the condition, the treatment and how stable you are, so ask for your own schedule rather than a general rule. Early on, a review to check inhaler technique and initial response is common, followed by regular visits with repeat spirometry or imaging. Some medicines require periodic blood tests. Between appointments, a written action plan and a named contact for questions matter as much as the visits themselves.

References

• CDC – About COPD
• NHS – Spirometry
• NHS – Chronic obstructive pulmonary disease (COPD): Treatment
• NHS – Idiopathic pulmonary fibrosis: Treatment

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.